184 related articles for article (PubMed ID: 16269466)
1. Insulin receptor kinase-associated phosphotyrosine phosphatases in hepatic endosomes: assessing the role of phosphotyrosine phosphatase-1B.
Li C; Baquiran G; Gu F; Tremblay ML; Fazel A; Bergeron JJ; Posner BI
Endocrinology; 2006 Feb; 147(2):912-8. PubMed ID: 16269466
[TBL] [Abstract][Full Text] [Related]
2. Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen).
Band CJ; Posner BI; Dumas V; Contreres JO
Mol Endocrinol; 1997 Dec; 11(13):1899-910. PubMed ID: 9415395
[TBL] [Abstract][Full Text] [Related]
3. A role for tyrosine phosphorylation in both activation and inhibition of the insulin receptor tyrosine kinase in vivo.
Drake PG; Bevan AP; Burgess JW; Bergeron JJ; Posner BI
Endocrinology; 1996 Nov; 137(11):4960-8. PubMed ID: 8895369
[TBL] [Abstract][Full Text] [Related]
4. Selective activation of the rat hepatic endosomal insulin receptor kinase. Role for the endosome in insulin signaling.
Bevan AP; Burgess JW; Drake PG; Shaver A; Bergeron JJ; Posner BI
J Biol Chem; 1995 May; 270(18):10784-91. PubMed ID: 7537739
[TBL] [Abstract][Full Text] [Related]
5. Regulation of insulin receptor kinase activity by endosomal processes: possible areas for therapeutic intervention.
Posner BI
Curr Opin Investig Drugs; 2003 Apr; 4(4):430-4. PubMed ID: 12808882
[TBL] [Abstract][Full Text] [Related]
6. Association of phosphatidylinositol 3-kinase with the insulin receptor: compartmentation in rat liver.
Drake PG; Balbis A; Wu J; Bergeron JJ; Posner BI
Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E266-74. PubMed ID: 10913025
[TBL] [Abstract][Full Text] [Related]
7. ATP-dependent desensitization of insulin binding and tyrosine kinase activity of the insulin receptor kinase. The role of endosomal acidification.
Contreres JO; Faure R; Baquiran G; Bergeron JJ; Posner BI
J Biol Chem; 1998 Aug; 273(34):22007-13. PubMed ID: 9705342
[TBL] [Abstract][Full Text] [Related]
8. Insulin receptor-associated protein tyrosine phosphatase(s): role in insulin action.
Drake PG; Posner BI
Mol Cell Biochem; 1998 May; 182(1-2):79-89. PubMed ID: 9609117
[TBL] [Abstract][Full Text] [Related]
9. Insulin Signalling: The Inside Story.
Posner BI
Can J Diabetes; 2017 Feb; 41(1):108-113. PubMed ID: 27614806
[TBL] [Abstract][Full Text] [Related]
10. Protein tyrosine phosphatase-1B dephosphorylation of the insulin receptor occurs in a perinuclear endosome compartment in human embryonic kidney 293 cells.
Romsicki Y; Reece M; Gauthier JY; Asante-Appiah E; Kennedy BP
J Biol Chem; 2004 Mar; 279(13):12868-75. PubMed ID: 14722096
[TBL] [Abstract][Full Text] [Related]
11. Peroxovanadium compounds: biological actions and mechanism of insulin-mimesis.
Bevan AP; Drake PG; Yale JF; Shaver A; Posner BI
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):49-58. PubMed ID: 8927047
[TBL] [Abstract][Full Text] [Related]
12. Peroxyvanadium compounds inhibit glucose-6-phosphatase activity and glucagon-stimulated hepatic glucose output in the rat in vivo.
Westergaard N; Brand CL; Lewinsky RH; Andersen HS; Carr RD; Burchell A; Lundgren K
Arch Biochem Biophys; 1999 Jun; 366(1):55-60. PubMed ID: 10334863
[TBL] [Abstract][Full Text] [Related]
13. Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics.
Posner BI; Faure R; Burgess JW; Bevan AP; Lachance D; Zhang-Sun G; Fantus IG; Ng JB; Hall DA; Lum BS
J Biol Chem; 1994 Feb; 269(6):4596-604. PubMed ID: 8308031
[TBL] [Abstract][Full Text] [Related]
14. SHP protein tyrosine phosphatase expression in rat uterine tissue.
Phillippe M; Bradley DF; Engle D; Sweet L
J Soc Gynecol Investig; 2006 Jul; 13(5):338-42. PubMed ID: 16814162
[TBL] [Abstract][Full Text] [Related]
15. Alteration of phosphotyrosine phosphatase activity in tissues from diabetic and pregnant rats.
Hauguel-de Mouzon S; Peraldi P; Alengrin F; Van Obberghen E
Endocrinology; 1993 Jan; 132(1):67-74. PubMed ID: 8419148
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms involved in the antiproliferative action of protein tyrosine phosphatase inhibitor potassium bisperoxo(1,10-phenanthroline)oxovanadate.
Ban J; Maysinger D; Kovac V; Galetić I; Matulić M; Hadzija M; Uzarević B
Life Sci; 2000 Dec; 68(2):165-75. PubMed ID: 11191635
[TBL] [Abstract][Full Text] [Related]
17. Insulin receptor internalization and signalling.
Di Guglielmo GM; Drake PG; Baass PC; Authier F; Posner BI; Bergeron JJ
Mol Cell Biochem; 1998 May; 182(1-2):59-63. PubMed ID: 9609114
[TBL] [Abstract][Full Text] [Related]
18. A 60-kilodalton protein in rat hepatoma cells overexpressing insulin receptor was tyrosine phosphorylated and associated with Syp, phophatidylinositol 3-kinase, and Grb2 in an insulin-dependent manner.
Zhang-Sun G; Yang C; Viallet J; Feng G; Bergeron JJ; Posner BI
Endocrinology; 1996 Jul; 137(7):2649-58. PubMed ID: 8770882
[TBL] [Abstract][Full Text] [Related]
19. Elevated protein tyrosine phosphatase activity and increased membrane viscosity are associated with impaired activation of the insulin receptor kinase in old rats.
Nadiv O; Shinitzky M; Manu H; Hecht D; Roberts CT; LeRoith D; Zick Y
Biochem J; 1994 Mar; 298 ( Pt 2)(Pt 2):443-50. PubMed ID: 8135754
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of a Src homology 2 domain containing protein tyrosine phosphatase by vanadate in the primary culture of hepatocytes.
Pugazhenthi S; Tanha F; Dahl B; Khandelwal RL
Arch Biochem Biophys; 1996 Nov; 335(2):273-82. PubMed ID: 8914924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
